Chiara Brando

Palermo, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications

POLE-mutated endometrial cancer: new perspectives on the horizon?

POLE-mutated endometrial cancer: new perspectives on the horizon?

Journal: Frontiers in oncology
Published: May 22, 2025

An intriguing journey into the hereditary syndromes predisposing to endometrial cancer: more than believed.

An intriguing journey into the hereditary syndromes predisposing to endometrial cancer: more than believed.

Journal: Therapeutic advances in medical oncology
Published: January 28, 2025

Scientific Communication and oncology - "The bridge between knowledge and patients".

Scientific Communication and oncology - "The bridge between knowledge and patients".

Journal: Critical reviews in oncology/hematology
Published: April 19, 2024

BRCA-associated hereditary male cancers: can gender affect the prevalence and spectrum of germline pathogenic variants?

BRCA-associated hereditary male cancers: can gender affect the prevalence and spectrum of germline pathogenic variants?

Journal: Frontiers in oncology
Published: April 08, 2024

BRCA functional domains associated with high risk of multiple primary tumors and domain-related sensitivity to olaparib: the Prometheus Study.

BRCA functional domains associated with high risk of multiple primary tumors and domain-related sensitivity to olaparib: the Prometheus Study.

Journal: ESMO open
Published: March 03, 2024

The intersection of homologous recombination (HR) and mismatch repair (MMR) pathways in DNA repair-defective tumors.

The intersection of homologous recombination (HR) and mismatch repair (MMR) pathways in DNA repair-defective tumors.

Journal: NPJ precision oncology
Published: February 19, 2024

Clinical relevance of exosome-derived microRNAs in Ovarian Cancer: Looking for new tumor biological fingerprints.

Clinical relevance of exosome-derived microRNAs in Ovarian Cancer: Looking for new tumor biological fingerprints.

Journal: Critical reviews in oncology/hematology
Published: August 30, 2023

Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking through a dirty glass window?

Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking through a dirty glass window?

Journal: Cancer treatment reviews
Published: August 30, 2023

Anthracycline-related cardiotoxicity in patients with breast cancer harboring mutational signature of homologous recombination deficiency (HRD).

Anthracycline-related cardiotoxicity in patients with breast cancer harboring mutational signature of homologous recombination deficiency (HRD).

Journal: ESMO open
Published: July 19, 2023

KIT/PDGFRA Variant Allele Frequency as Prognostic Factor in Gastrointestinal Stromal Tumors (GISTs): Results From a Multi-Institutional Cohort Study.

KIT/PDGFRA Variant Allele Frequency as Prognostic Factor in Gastrointestinal Stromal Tumors (GISTs): Results From a Multi-Institutional Cohort Study.

Journal: The oncologist
Published: April 04, 2023

Potential agnostic role of BRCA alterations in patients with several solid tumors: One for all, all for one?

Potential agnostic role of BRCA alterations in patients with several solid tumors: One for all, all for one?

Journal: Critical reviews in oncology/hematology
Published: March 21, 2023

Low plasma PD-L1 levels, early tumor onset and absence of peritoneal carcinomatosis improve prognosis of women with advanced high-grade serous ovarian cancer.

Low plasma PD-L1 levels, early tumor onset and absence of peritoneal carcinomatosis improve prognosis of women with advanced high-grade serous ovarian cancer.

Journal: BMC cancer
Published: January 12, 2023
Showing 1-12 of 33

Last Updated: 09/26/2026